group,serum,virus,replicate,titer,titer_bound,titer_as,nt50,midpoint,top,bottom,slope
MA22VaccineCohort,AUS24_s006_prevax,A/SouthSudan/642/2023,plate40-GCTAATTCCAAAAGCG,40,upper,midpoint,40,40,0.9659,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/SouthSudan/642/2023,plate40-TCTTAACTACCCGATG,40,upper,midpoint,40,40,0.984,0,1.212
MA22VaccineCohort,AUS24_s006_prevax,A/SouthSudan/642/2023,plate40-AATCTTTCCAATCTTG,40,upper,midpoint,40,40,0.9616,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Darwin/6/2021,plate40-CTATCTTAATCTACAG,40,upper,midpoint,40,40,0.9643,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Darwin/6/2021,plate40-GTTATTATGACTTCAT,40,upper,midpoint,40,40,0.9651,0,5.57
MA22VaccineCohort,AUS24_s006_prevax,A/Darwin/6/2021,plate40-CAATTCGCCGTTCCCC,40,upper,midpoint,40,40,0.9877,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Switzerland/9715293/2013,plate40-TCGATTACTAGCCGGA,40,upper,midpoint,40,40,0.9573,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Switzerland/9715293/2013,plate40-AGCTGAATTAAGTATG,40,upper,midpoint,40,40,0.9919,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Switzerland/9715293/2013,plate40-CCAATCCCAGCCTTTA,40,upper,midpoint,40,40,0.9796,0,0.8
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/332/2023,plate40-TATTATCTAAACGGCG,46.29,interpolated,midpoint,47.67,46.29,0.9633,0,2.602
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/332/2023,plate40-CCCCAGGTATAAAATA,66.93,interpolated,midpoint,68.5,66.93,0.9636,0,3.262
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/332/2023,plate40-GCCCATTGAACGCAGC,57.14,interpolated,midpoint,58.4,57.14,0.969,0,2.941
MA22VaccineCohort,AUS24_s006_prevax,A/Solwezi/13-NIC-001/2023,plate40-CCACGTTCATTAGATG,40,upper,midpoint,40,40,0.9556,0,2.179
MA22VaccineCohort,AUS24_s006_prevax,A/Solwezi/13-NIC-001/2023,plate40-AAACTTCGTGGTATAC,40,upper,midpoint,40.27,40,0.9472,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Solwezi/13-NIC-001/2023,plate40-TAGTTGCCCCGACCTG,42.26,interpolated,midpoint,43.05,42.26,0.9158,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Bangkok/P3755/2023,plate40-TATCATTTCATCTACA,40,upper,midpoint,40,40,0.9921,0,1.392
MA22VaccineCohort,AUS24_s006_prevax,A/Bangkok/P3755/2023,plate40-TAGCTGGGCAAAGGCT,40,upper,midpoint,41.1,40,0.8784,0,2.751
MA22VaccineCohort,AUS24_s006_prevax,A/Bangkok/P3755/2023,plate40-CGCAAGGGATACTAAC,43.37,interpolated,midpoint,43.55,43.37,0.9797,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06506/2023,plate40-AAATACCCTTGAGATA,40,upper,midpoint,40,40,0.9922,0,0.9874
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06506/2023,plate40-AAGTGGTAGGATAAAA,52.77,interpolated,midpoint,60.53,52.77,0.7479,0,5.113
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06506/2023,plate40-ACCCTTTTAGATATGA,75.43,interpolated,midpoint,78.78,75.43,0.9668,0,1.575
MA22VaccineCohort,AUS24_s006_prevax,A/SouthSudan/631/2023,plate40-CTGAAACCTTGTCCTA,40,upper,midpoint,40,40,0.9646,0,5.695
MA22VaccineCohort,AUS24_s006_prevax,A/SouthSudan/631/2023,plate40-CCAATAAAATACGATG,51.02,interpolated,midpoint,51.27,51.02,0.9926,0,3.048
MA22VaccineCohort,AUS24_s006_prevax,A/SouthSudan/631/2023,plate40-TTAGTCATCTGGGTGC,44.38,interpolated,midpoint,47.09,44.38,0.9428,0,2.045
MA22VaccineCohort,AUS24_s006_prevax,A/California/81/2023,plate40-ATTTATATTGTCGAAC,40,upper,midpoint,40,40,0.9215,0,0.9113
MA22VaccineCohort,AUS24_s006_prevax,A/California/81/2023,plate40-TTATGATCGAGGTAAA,41.2,interpolated,midpoint,42.5,41.2,0.9794,0,1.352
MA22VaccineCohort,AUS24_s006_prevax,A/California/81/2023,plate40-CCGATAAGACGTCGCT,57.65,interpolated,midpoint,59.26,57.65,0.9683,0,2.385
MA22VaccineCohort,AUS24_s006_prevax,A/Catalonia/NSVH102124476/2023,plate40-ACTGAACAGTATAACT,41.51,interpolated,midpoint,43.22,41.51,0.954,0,2.389
MA22VaccineCohort,AUS24_s006_prevax,A/Catalonia/NSVH102124476/2023,plate40-CTAAGGGCCTGTTCTT,43.6,interpolated,midpoint,44.01,43.6,0.9706,0,6.49
MA22VaccineCohort,AUS24_s006_prevax,A/Catalonia/NSVH102124476/2023,plate40-AATATACCGGCACTAC,56.61,interpolated,midpoint,58.76,56.61,0.9661,0,1.882
MA22VaccineCohort,AUS24_s006_prevax,A/Busan/1301/2023,plate40-GCATTATAATCTTGTG,65.94,interpolated,midpoint,77.45,65.94,0.8762,0,1.768
MA22VaccineCohort,AUS24_s006_prevax,A/Busan/1301/2023,plate40-TAAAAGAATGATGGTC,65.1,interpolated,midpoint,73.04,65.1,0.8761,0,2.474
MA22VaccineCohort,AUS24_s006_prevax,A/Busan/1301/2023,plate40-AATCCGGTTAACCCCG,75.64,interpolated,midpoint,87.67,75.64,0.8585,0,2.255
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R05384/2023,plate40-CTTACAAAGGTAATTC,40,upper,midpoint,40,40,0.9866,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R05384/2023,plate40-TTACGTCAATGTTTGA,40.43,interpolated,midpoint,40.85,40.43,0.9504,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R05384/2023,plate40-TTTATGCCGATAGAGA,40,upper,midpoint,40,40,0.9581,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/South_Dakota/22/2023,plate40-TCAACCCTTCGATGTA,55.88,interpolated,midpoint,61.47,55.88,0.905,0,2.211
MA22VaccineCohort,AUS24_s006_prevax,A/South_Dakota/22/2023,plate40-GAAGTAACAAACTATG,50.08,interpolated,midpoint,50.35,50.08,0.9894,0,3.885
MA22VaccineCohort,AUS24_s006_prevax,A/South_Dakota/22/2023,plate40-AGGGACTTTATTGTCC,56.87,interpolated,midpoint,58.13,56.87,0.9466,0,5.162
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/45/2019,plate40-TAAAAAGCCTCCATGA,40.04,interpolated,midpoint,40.08,40.04,0.9947,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/45/2019,plate40-CGGGGACAAGATTGTA,40.22,interpolated,midpoint,40.88,40.22,0.9753,0,3.118
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/45/2019,plate40-TATCCAAGGGACGGAC,41.1,interpolated,midpoint,41.24,41.1,0.9831,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/710/2023,plate40-CTTGTAAAACTATGAT,52.11,interpolated,midpoint,53.9,52.11,0.9616,0,2.37
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/710/2023,plate40-GCCGTAGCGAAATCTT,67.29,interpolated,midpoint,73.65,67.29,0.8749,0,3.192
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/710/2023,plate40-TGATCCGCAAGCTTAG,50.61,interpolated,midpoint,55.48,50.61,0.7986,0,5.613
MA22VaccineCohort,AUS24_s006_prevax,A/Cambodia/e0826360/2020,plate40-TTGCAATTGAAACATA,40,upper,midpoint,40,40,0.9962,0,9.487
MA22VaccineCohort,AUS24_s006_prevax,A/Cambodia/e0826360/2020,plate40-ATTAGATTATAACGTA,40,upper,midpoint,40,40,1,0,9.997
MA22VaccineCohort,AUS24_s006_prevax,A/Cambodia/e0826360/2020,plate40-TTGACTCACCGAATAA,40,upper,midpoint,40,40,0.9526,0,9.993
MA22VaccineCohort,AUS24_s006_prevax,A/SOUTH_AFRICA/R07876/202023,plate40-TGATTCGTCAATTCAT,63.43,interpolated,midpoint,67.52,63.43,0.9359,0,2.199
MA22VaccineCohort,AUS24_s006_prevax,A/SOUTH_AFRICA/R07876/202023,plate40-AGACTGTACGCGACAG,70.6,interpolated,midpoint,72.34,70.6,0.9678,0,2.729
MA22VaccineCohort,AUS24_s006_prevax,A/SOUTH_AFRICA/R07876/202023,plate40-CTACTAGAGCAGCGAG,81.4,interpolated,midpoint,88.92,81.4,0.9136,0,2.148
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/FLU-BTG-00988/2022,plate40-CAAGAAATGTAGTGAA,45.45,interpolated,midpoint,46.46,45.45,0.9692,0,2.888
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/FLU-BTG-00988/2022,plate40-GGTTGCGTAGTTAATC,41.52,interpolated,midpoint,42.2,41.52,0.9251,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/FLU-BTG-00988/2022,plate40-TCGCGGTAGATTTGCG,41.14,interpolated,midpoint,41.87,41.14,0.9693,0,3.586
MA22VaccineCohort,AUS24_s006_prevax,A/Townsville/68/2023,plate40-ACAGTACAGATATGAC,68.85,interpolated,midpoint,75.46,68.85,0.8871,0,2.794
MA22VaccineCohort,AUS24_s006_prevax,A/Townsville/68/2023,plate40-GTTATAGAGTGCTTAC,55.75,interpolated,midpoint,61.13,55.75,0.8901,0,2.694
MA22VaccineCohort,AUS24_s006_prevax,A/Townsville/68/2023,plate40-TCCCGAACTGAACGCG,66.39,interpolated,midpoint,81.34,66.39,0.8409,0,1.886
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/715/2023,plate40-TACGACGGAAACAGAA,72.53,interpolated,midpoint,74.91,72.53,0.9725,0,1.749
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/715/2023,plate40-CTACACTACATCAAAT,74.99,interpolated,midpoint,76.16,74.99,0.9798,0,2.651
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/715/2023,plate40-AATGACAGCTGTCTAG,48.73,interpolated,midpoint,49.66,48.73,0.9135,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Luga/RII-11393S/2023,plate40-ATGGTTATCTTACCTT,40,upper,midpoint,40,40,0.9607,0,1.927
MA22VaccineCohort,AUS24_s006_prevax,A/Luga/RII-11393S/2023,plate40-CGTCAGAAGTTTATAA,40,upper,midpoint,40,40,0.9148,0,1.177
MA22VaccineCohort,AUS24_s006_prevax,A/Luga/RII-11393S/2023,plate40-CTCATTACAGAAATTG,44.07,interpolated,midpoint,44.58,44.07,0.9452,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Singapore/INFIMH-16-0019/2016,plate40-CGTACAGTGTAATCGA,40,upper,midpoint,40,40,0.9795,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Singapore/INFIMH-16-0019/2016,plate40-TACTAGCAATAAAATC,40,upper,midpoint,40,40,0.9659,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Singapore/INFIMH-16-0019/2016,plate40-TACCAATGTCATTTGA,44.44,interpolated,midpoint,44.84,44.44,0.9829,0,3.847
MA22VaccineCohort,AUS24_s006_prevax,A/YAMAGATA/98/2023,plate40-CAACGTGATGAGGAAG,53.81,interpolated,midpoint,58.22,53.81,0.8948,0,2.999
MA22VaccineCohort,AUS24_s006_prevax,A/YAMAGATA/98/2023,plate40-TTAGCAGTTAACGTAT,68.45,interpolated,midpoint,93.42,68.45,0.7788,0,1.879
MA22VaccineCohort,AUS24_s006_prevax,A/YAMAGATA/98/2023,plate40-CCCGCTAACCCTGTCT,40,upper,midpoint,42.43,40,0.6739,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01685/2023,plate40-GCATCCTTGTGTCGAA,61.71,interpolated,midpoint,64.65,61.71,0.9629,0,1.661
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01685/2023,plate40-TGAGATCAGCCGGGTG,66.7,interpolated,midpoint,70.34,66.7,0.9345,0,2.641
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01685/2023,plate40-GGCTATATATCTGTTT,82.4,interpolated,midpoint,84.6,82.4,0.8842,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/TECPAN/017FLU/2023,plate40-TACTGAGACACTTAAA,45.9,interpolated,midpoint,50.34,45.9,0.9104,0,2.139
MA22VaccineCohort,AUS24_s006_prevax,A/TECPAN/017FLU/2023,plate40-ATAATAATCATCAAGA,45.2,interpolated,midpoint,46.99,45.2,0.9598,0,2.158
MA22VaccineCohort,AUS24_s006_prevax,A/TECPAN/017FLU/2023,plate40-CACCTTCATCCTAAAG,56.8,interpolated,midpoint,62.78,56.8,0.9149,0,1.867
MA22VaccineCohort,AUS24_s006_prevax,A/Krabi/THIS050/2023,plate40-CGCGAACAACAGGGGA,94.13,interpolated,midpoint,102.3,94.13,0.9501,0,1.267
MA22VaccineCohort,AUS24_s006_prevax,A/Krabi/THIS050/2023,plate40-TTAGCTACTAACCCGT,74.71,interpolated,midpoint,85.09,74.71,0.8793,0,2.124
MA22VaccineCohort,AUS24_s006_prevax,A/Krabi/THIS050/2023,plate40-AATTAATGGTAATAAA,72.13,interpolated,midpoint,79.49,72.13,0.9085,0,2.077
MA22VaccineCohort,AUS24_s006_prevax,A/Saint-Petersburg/RII-MH144113/2023,plate40-GCTTTTGAGAACCATT,61.07,interpolated,midpoint,66.39,61.07,0.9154,0,2.222
MA22VaccineCohort,AUS24_s006_prevax,A/Saint-Petersburg/RII-MH144113/2023,plate40-CCGGTTTTCGGGACCT,43.05,interpolated,midpoint,55.37,43.05,0.8628,0,1.275
MA22VaccineCohort,AUS24_s006_prevax,A/Saint-Petersburg/RII-MH144113/2023,plate40-ATAAAGAATCCCTTGA,64.32,interpolated,midpoint,69.73,64.32,0.905,0,2.61
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R07073/2023,plate40-CGGCTAAAGTCTATAG,54.1,interpolated,midpoint,59.54,54.1,0.8935,0,2.496
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R07073/2023,plate40-CATCATTATTACAAAG,69.57,interpolated,midpoint,73.34,69.57,0.9561,0,1.741
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R07073/2023,plate40-CACCCAAACGTTCGCA,62.17,interpolated,midpoint,74.78,62.17,0.8319,0,2.219
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/4801/2014,plate40-AAGTATTGCTACACAT,40,upper,midpoint,40,40,0.9996,0,4.065
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/4801/2014,plate40-TCTTAGAGTGAACGAT,40,upper,midpoint,40,40,0.9891,0,3.274
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/4801/2014,plate40-ATTTTTCTATGGCTAC,43.23,interpolated,midpoint,43.29,43.23,0.9924,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Finland/399/2023,plate40-TCAATGAATGCGGGGT,43.46,interpolated,midpoint,45.45,43.46,0.9457,0,2.572
MA22VaccineCohort,AUS24_s006_prevax,A/Finland/399/2023,plate40-CCACAAGTTTGAAAAC,52.17,interpolated,midpoint,53.65,52.17,0.9495,0,3.793
MA22VaccineCohort,AUS24_s006_prevax,A/Finland/399/2023,plate40-CCAGAGACACGCTAGG,61.39,interpolated,midpoint,62.13,61.39,0.987,0,2.189
MA22VaccineCohort,AUS24_s006_prevax,A/Samut_Songkhram/THIS061/2023,plate40-GAGATAGCCCAGAGGT,65.61,interpolated,midpoint,70.19,65.61,0.9391,0,1.924
MA22VaccineCohort,AUS24_s006_prevax,A/Samut_Songkhram/THIS061/2023,plate40-CCTATTATAGCTAACA,46.08,interpolated,midpoint,46.9,46.08,0.9197,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Samut_Songkhram/THIS061/2023,plate40-AAGTTGTACTTAAGGC,78.8,interpolated,midpoint,84.12,78.8,0.9089,0,3.082
MA22VaccineCohort,AUS24_s006_prevax,A/Surat_Thani/P152/2023,plate40-CAATGGATAATGATAG,69.32,interpolated,midpoint,81,69.32,0.8553,0,2.194
MA22VaccineCohort,AUS24_s006_prevax,A/Surat_Thani/P152/2023,plate40-TTACGACGTCATGTAT,74.79,interpolated,midpoint,88.44,74.79,0.8545,0,2.052
MA22VaccineCohort,AUS24_s006_prevax,A/Surat_Thani/P152/2023,plate40-GATTCACGGCCCACAA,84.86,interpolated,midpoint,101.2,84.86,0.8345,0,2.284
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06359/2023,plate40-AGTTATGTAAAACGTG,65.81,interpolated,midpoint,76.76,65.81,0.8497,0,2.322
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06359/2023,plate40-CGCAGTACACAACAAG,58.84,interpolated,midpoint,67.27,58.84,0.8488,0,2.689
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06359/2023,plate40-CATAATGCACAAACGC,80.01,interpolated,midpoint,93.75,80.01,0.8394,0,2.446
MA22VaccineCohort,AUS24_s006_prevax,A/EHIME/50/2023,plate40-CGCGAATCACTAAGTA,46.32,interpolated,midpoint,48.22,46.32,0.9492,0,2.672
MA22VaccineCohort,AUS24_s006_prevax,A/EHIME/50/2023,plate40-CAGTAGCAAAACATGC,56.56,interpolated,midpoint,60.22,56.56,0.9243,0,2.618
MA22VaccineCohort,AUS24_s006_prevax,A/EHIME/50/2023,plate40-TTATAATGGCCGGTAT,49.96,interpolated,midpoint,51.44,49.96,0.9516,0,3.505
MA22VaccineCohort,AUS24_s006_prevax,A/Chipata/15-NIC-001/2023,plate40-CGTATAACTGACGATT,77.07,interpolated,midpoint,94.71,77.07,0.8312,0,1.999
MA22VaccineCohort,AUS24_s006_prevax,A/Chipata/15-NIC-001/2023,plate40-CAGTGCCATCCATCCA,67.34,interpolated,midpoint,74.76,67.34,0.9259,0,1.536
MA22VaccineCohort,AUS24_s006_prevax,A/Chipata/15-NIC-001/2023,plate40-TTTCATATAATTTGAG,105.5,interpolated,midpoint,117.7,105.5,0.9209,0,1.566
MA22VaccineCohort,AUS24_s006_prevax,A/Catalonia/2041146NS/2023,plate40-TAGATAATAAGATTCA,40,upper,midpoint,41.16,40,0.8669,0,2.922
MA22VaccineCohort,AUS24_s006_prevax,A/Catalonia/2041146NS/2023,plate40-GACATCAAATAGCAAC,50.89,interpolated,midpoint,52.81,50.89,0.9199,0,4.705
MA22VaccineCohort,AUS24_s006_prevax,A/Catalonia/2041146NS/2023,plate40-AGATCATAAGCAATAA,56.05,interpolated,midpoint,57.79,56.05,0.9514,0,3.331
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01760/2023,plate40-AACAAGGCCAACATTT,43.88,interpolated,midpoint,45.49,43.88,0.9542,0,2.675
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01760/2023,plate40-AATCCGATAAGAGCTA,61.66,interpolated,midpoint,64.05,61.66,0.9585,0,2.276
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01760/2023,plate40-CTGTGAAAAAAAATAC,59.31,interpolated,midpoint,63.21,59.31,0.9201,0,2.736
MA22VaccineCohort,AUS24_s006_prevax,A/Georgia/40/2023,plate40-CCACGCACTTAAATAA,57.59,interpolated,midpoint,62.19,57.59,0.9122,0,2.512
MA22VaccineCohort,AUS24_s006_prevax,A/Georgia/40/2023,plate40-CCCATATACTCACAGA,60.88,interpolated,midpoint,63.29,60.88,0.9545,0,2.454
MA22VaccineCohort,AUS24_s006_prevax,A/Georgia/40/2023,plate40-CCATATATAAGAAACC,78.07,interpolated,midpoint,80.33,78.07,0.9748,0,1.809
MA22VaccineCohort,AUS24_s006_prevax,A/Kansas/14/2017,plate40-GCAACGAGGTGTAACC,40,upper,midpoint,40,40,0.9821,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Kansas/14/2017,plate40-AACCACCCCAGAGATG,40,upper,midpoint,40,40,0.9745,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Kansas/14/2017,plate40-TATACTCACGGAGGAT,70.73,interpolated,midpoint,71.78,70.73,0.9704,0,4.147
MA22VaccineCohort,AUS24_s006_prevax,A/Oman/3011/2023,plate40-TACGAAAATCAAGAGC,48.63,interpolated,midpoint,51.6,48.63,0.9361,0,2.305
MA22VaccineCohort,AUS24_s006_prevax,A/Oman/3011/2023,plate40-TCCTTTAACTAATCGA,74.91,interpolated,midpoint,77.3,74.91,0.9617,0,2.538
MA22VaccineCohort,AUS24_s006_prevax,A/Oman/3011/2023,plate40-AATAGGCCCAAATCCA,74.28,interpolated,midpoint,82.67,74.28,0.8873,0,2.388
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R05510/2023,plate40-CACCACAGTTACTTAA,157.2,interpolated,midpoint,215.5,157.2,0.8048,0,1.57
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R05510/2023,plate40-CGCCGAACGGCGGCGC,135.3,interpolated,midpoint,201.2,135.3,0.7576,0,1.672
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R05510/2023,plate40-TCCGCCACTATAACAT,188.2,interpolated,midpoint,247.7,188.2,0.8415,0,1.388
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/0006/2023,plate40-GAAAATCGAGCTTTAA,48.95,interpolated,midpoint,49.88,48.95,0.972,0,3.036
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/0006/2023,plate40-GACCTCCTGGGCACGC,43.41,interpolated,midpoint,44.83,43.41,0.9632,0,2.369
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/0006/2023,plate40-CAAAAAGCTAATAAGT,43.67,interpolated,midpoint,44.11,43.67,0.9519,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Saskatchewan/SKFLU317847/2023,plate40-GTTTTTCACTGAGTAG,56.45,interpolated,midpoint,59.99,56.45,0.9231,0,2.748
MA22VaccineCohort,AUS24_s006_prevax,A/Saskatchewan/SKFLU317847/2023,plate40-GACCAAAAAGCAGTAT,76.77,interpolated,midpoint,82.92,76.77,0.9223,0,2.192
MA22VaccineCohort,AUS24_s006_prevax,A/Saskatchewan/SKFLU317847/2023,plate40-AGCATGAGCTTGTCAT,67.8,interpolated,midpoint,68.66,67.8,0.987,0,2.084
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06477/2023,plate40-GATCTGCTTGGAATGT,71.69,interpolated,midpoint,82.5,71.69,0.8988,0,1.609
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06477/2023,plate40-TAAACAAAACCTATAC,69.69,interpolated,midpoint,88.51,69.69,0.8057,0,2.058
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06477/2023,plate40-ATTCAATACGTACTTA,58.2,interpolated,midpoint,61.54,58.2,0.9016,0,3.931
MA22VaccineCohort,AUS24_s006_prevax,A/KANAGAWA/AC2316/2023,plate40-TGCCGATCCAATTGAT,69.73,interpolated,midpoint,73.59,69.73,0.9421,0,2.283
MA22VaccineCohort,AUS24_s006_prevax,A/KANAGAWA/AC2316/2023,plate40-CTTGAATACACAAACA,85.48,interpolated,midpoint,101.5,85.48,0.8172,0,2.651
MA22VaccineCohort,AUS24_s006_prevax,A/KANAGAWA/AC2316/2023,plate40-TATCCTTGAGTGGCTC,88.92,interpolated,midpoint,117.8,88.92,0.8611,0,1.158
MA22VaccineCohort,AUS24_s006_prevax,A/Maldives/852/2023,plate40-AAGCTAATCGTAGTCC,41.26,interpolated,midpoint,41.6,41.26,0.9724,0,6.983
MA22VaccineCohort,AUS24_s006_prevax,A/Maldives/852/2023,plate40-GGGTGCAATGAATCCA,55.26,interpolated,midpoint,56.74,55.26,0.9384,0,4.985
MA22VaccineCohort,AUS24_s006_prevax,A/Maldives/852/2023,plate40-CAGCCGCTAAAATGAT,53.33,interpolated,midpoint,63.55,53.33,0.8785,0,1.59
MA22VaccineCohort,AUS24_s006_prevax,A/KANAGAWA/IC2239/2023,plate40-TGTAGTATAAGAATAA,88.46,interpolated,midpoint,108.8,88.46,0.8552,0,1.655
MA22VaccineCohort,AUS24_s006_prevax,A/KANAGAWA/IC2239/2023,plate40-GACCAAAGCTGCAGGG,53.25,interpolated,midpoint,62.04,53.25,0.8652,0,2.054
MA22VaccineCohort,AUS24_s006_prevax,A/KANAGAWA/IC2239/2023,plate40-ACGTAAATCCCCACAA,81.93,interpolated,midpoint,87.42,81.93,0.9498,0,1.632
MA22VaccineCohort,AUS24_s006_prevax,A/Massachusetts/18/2022,plate40-CATTTCTGATGAATTG,77.7,interpolated,midpoint,83.47,77.7,0.934,0,1.975
MA22VaccineCohort,AUS24_s006_prevax,A/Massachusetts/18/2022,plate40-TCCACACCCCTAGCTA,83.72,interpolated,midpoint,90.84,83.72,0.8623,0,3.947
MA22VaccineCohort,AUS24_s006_prevax,A/Massachusetts/18/2022,plate40-CGATCTTTACGAAAAA,87.47,interpolated,midpoint,89.76,87.47,0.9752,0,1.971
MA22VaccineCohort,AUS24_s006_prevax,A/Abu_Dhabi/6753/2023,plate40-TATCGCAATATGATAA,43.51,interpolated,midpoint,44.67,43.51,0.9334,0,5.452
MA22VaccineCohort,AUS24_s006_prevax,A/Abu_Dhabi/6753/2023,plate40-TCTTGAATTTCATGGA,50.62,interpolated,midpoint,51.52,50.62,0.9694,0,3.59
MA22VaccineCohort,AUS24_s006_prevax,A/Abu_Dhabi/6753/2023,plate40-GCTGGTGCACAAGATT,41.97,interpolated,midpoint,42.52,41.97,0.9391,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/KO56863/2023,plate40-CCGCTATCATTAACCC,97.2,interpolated,midpoint,114.2,97.2,0.8863,0,1.604
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/KO56863/2023,plate40-GAGCCCGAATAGCAAG,54.28,interpolated,midpoint,55.2,54.28,0.9557,0,5.491
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/KO56863/2023,plate40-ATCGTCCCGGACATTT,102.5,interpolated,midpoint,113.2,102.5,0.9322,0,1.467
MA22VaccineCohort,AUS24_s006_prevax,A/Bangkok/P3599/2023,plate40-GAAAGAAAGCTATATG,104,interpolated,midpoint,106,104,0.9881,0,1.259
MA22VaccineCohort,AUS24_s006_prevax,A/Bangkok/P3599/2023,plate40-AGGTGCGAGCCATCAG,125.7,interpolated,midpoint,137.2,125.7,0.955,0,1.076
MA22VaccineCohort,AUS24_s006_prevax,A/Bangkok/P3599/2023,plate40-TTACATTTTTAGAATT,83.93,interpolated,midpoint,113.3,83.93,0.8122,0,1.568
MA22VaccineCohort,AUS24_s006_prevax,A/Schleswig-Holstein/4/2023,plate40-CCAATCATGTATCACA,73.54,interpolated,midpoint,78.76,73.54,0.9406,0,1.845
MA22VaccineCohort,AUS24_s006_prevax,A/Schleswig-Holstein/4/2023,plate40-ACGGACAACCTATCGC,82.85,interpolated,midpoint,103.8,82.85,0.8307,0,1.835
MA22VaccineCohort,AUS24_s006_prevax,A/Schleswig-Holstein/4/2023,plate40-ACTATACATAGAAGAA,74.51,interpolated,midpoint,80.17,74.51,0.9246,0,2.232
MA22VaccineCohort,AUS24_s006_prevax,A/Brisbane/429/2023,plate40-TTGCTAGTCTACCTGA,69.86,interpolated,midpoint,79.35,69.86,0.8826,0,2.102
MA22VaccineCohort,AUS24_s006_prevax,A/Brisbane/429/2023,plate40-TTAACCTAACGTATAG,110.1,interpolated,midpoint,130.5,110.1,0.8852,0,1.534
MA22VaccineCohort,AUS24_s006_prevax,A/Brisbane/429/2023,plate40-CTCCAATAGGAGACGA,153.5,interpolated,midpoint,153.5,153.5,1,0,0.8921
MA22VaccineCohort,AUS24_s006_prevax,A/Ontario/RV00796/2023,plate40-TCCAAACAGCGTTAAA,44.6,interpolated,midpoint,46.21,44.6,0.9288,0,4.332
MA22VaccineCohort,AUS24_s006_prevax,A/Ontario/RV00796/2023,plate40-TACCATTTTGGTCCGC,44.85,interpolated,midpoint,45.07,44.85,0.9757,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Ontario/RV00796/2023,plate40-TGGCTAGCGCACACCA,68.15,interpolated,midpoint,71.08,68.15,0.9392,0,3.086
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01693/2023,plate40-AACGACACTTACATCC,64.44,interpolated,midpoint,67.05,64.44,0.9495,0,2.686
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01693/2023,plate40-AAGCGGTTTAGGTCCA,58.85,interpolated,midpoint,62.17,58.85,0.9346,0,2.55
MA22VaccineCohort,AUS24_s006_prevax,A/Netherlands/01693/2023,plate40-CCATCACCTTATACAC,58.6,interpolated,midpoint,63.99,58.6,0.8686,0,3.465
MA22VaccineCohort,AUS24_s006_prevax,A/Switzerland/9715293/2013_NIB-88,plate40-CGGGAAATGTAAATGA,43.44,interpolated,midpoint,43.98,43.44,0.9416,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Switzerland/9715293/2013_NIB-88,plate40-ATAGGATATATGGCTG,60.42,interpolated,midpoint,63.78,60.42,0.9203,0,3.214
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/0845/2023,plate40-AACAATTAATTTTTCA,47.65,interpolated,midpoint,50.03,47.65,0.9572,0,1.839
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/0845/2023,plate40-GACAGAAACAAAATTA,43.91,interpolated,midpoint,43.92,43.91,0.9998,0,2.714
MA22VaccineCohort,AUS24_s006_prevax,A/Bhutan/0845/2023,plate40-AAGAAATTATGGCAGG,54.66,interpolated,midpoint,54.77,54.66,0.9963,0,3.664
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/K056872/2023,plate40-ATCGAAAAAACTGCAA,76.6,interpolated,midpoint,84.33,76.6,0.8453,0,3.853
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/K056872/2023,plate40-GCTGAAGACAGTATTA,67.19,interpolated,midpoint,70.84,67.19,0.8958,0,4.417
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/K056872/2023,plate40-AAGAAAACGGAAAGAA,77.03,interpolated,midpoint,82.64,77.03,0.9009,0,3.144
MA22VaccineCohort,AUS24_s006_prevax,A/Wisconsin/27/2023,plate40-AGATGGAGGAATAAAC,73.19,interpolated,midpoint,84.98,73.19,0.8588,0,2.221
MA22VaccineCohort,AUS24_s006_prevax,A/Wisconsin/27/2023,plate40-CAAGACAAGCCCTATA,60.64,interpolated,midpoint,63.67,60.64,0.889,0,5.157
MA22VaccineCohort,AUS24_s006_prevax,A/Wisconsin/27/2023,plate40-CCTATAAGGCCTTACG,98.61,interpolated,midpoint,102.7,98.61,0.933,0,3.518
MA22VaccineCohort,AUS24_s006_prevax,A/SouthAfrica/PET28931/2023,plate40-ACCGTTTTTCTACCAG,74.97,interpolated,midpoint,82.07,74.97,0.9027,0,2.391
MA22VaccineCohort,AUS24_s006_prevax,A/SouthAfrica/PET28931/2023,plate40-GGCAATAAGTTAAATG,59.89,interpolated,midpoint,64.51,59.89,0.8857,0,3.494
MA22VaccineCohort,AUS24_s006_prevax,A/SouthAfrica/PET28931/2023,plate40-AAAACAGGTCCGGTTT,71.87,interpolated,midpoint,81.28,71.87,0.8786,0,2.261
MA22VaccineCohort,AUS24_s006_prevax,A/Romania/543634/2022,plate40-TTTACTCGACTAACCG,91.56,interpolated,midpoint,103.9,91.56,0.8887,0,1.986
MA22VaccineCohort,AUS24_s006_prevax,A/Romania/543634/2022,plate40-CACGTTAGTGAGACTT,101.3,interpolated,midpoint,111.6,101.3,0.9271,0,1.621
MA22VaccineCohort,AUS24_s006_prevax,A/Romania/543634/2022,plate40-CTTCATCTCATTTAAA,123,interpolated,midpoint,171.9,123,0.8396,0,1.155
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R07188/2023,plate40-TAAACTGTAACTTACA,79.72,interpolated,midpoint,87.29,79.72,0.9229,0,1.847
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R07188/2023,plate40-AGTGCTATAAAAATCA,62.23,interpolated,midpoint,66.46,62.23,0.9156,0,2.816
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R07188/2023,plate40-AAATGCTGAGAGGGTA,68.41,interpolated,midpoint,82.29,68.41,0.8127,0,2.541
MA22VaccineCohort,AUS24_s006_prevax,A/Jeju/1047/2023,plate40-AAATTTTTCTTTAGAC,92.61,interpolated,midpoint,104.4,92.61,0.9026,0,1.812
MA22VaccineCohort,AUS24_s006_prevax,A/Jeju/1047/2023,plate40-TGAATTGCGTGATGGG,54.68,interpolated,midpoint,58.63,54.68,0.827,0,6.086
MA22VaccineCohort,AUS24_s006_prevax,A/Jeju/1047/2023,plate40-AATGGTCGAGCCATTC,78.94,interpolated,midpoint,86.99,78.94,0.8674,0,3.175
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06240/2023,plate40-CATATTCTAAAATTGA,81.69,interpolated,midpoint,91.47,81.69,0.9041,0,1.884
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06240/2023,plate40-CACCGACCAACTCTCT,40,upper,midpoint,40,40,0.9342,0,0.8
MA22VaccineCohort,AUS24_s006_prevax,A/South_Africa/R06240/2023,plate40-AGAAAAACGACATCAT,99.1,interpolated,midpoint,109.1,99.1,0.9129,0,1.992
MA22VaccineCohort,AUS24_s006_prevax,A/SENDAI/45/2023,plate40-CTGCGAATATTGTGAC,52.18,interpolated,midpoint,54.12,52.18,0.9226,0,4.6
MA22VaccineCohort,AUS24_s006_prevax,A/SENDAI/45/2023,plate40-AAAGATAAATTCAAAA,63.99,interpolated,midpoint,69.68,63.99,0.9357,0,1.614
MA22VaccineCohort,AUS24_s006_prevax,A/SENDAI/45/2023,plate40-TGACAAACACCTGAGG,58.3,interpolated,midpoint,64.69,58.3,0.9041,0,2.047
MA22VaccineCohort,AUS24_s006_prevax,A/Finland/391/2023,plate40-TATCAATTCGGTATTA,67.5,interpolated,midpoint,74.16,67.5,0.8677,0,3.261
MA22VaccineCohort,AUS24_s006_prevax,A/Finland/391/2023,plate40-AGCTATGCCTAGTGAA,76.07,interpolated,midpoint,101.8,76.07,0.8208,0,1.522
MA22VaccineCohort,AUS24_s006_prevax,A/Finland/391/2023,plate40-CCGCAATGACAATTTG,84.68,interpolated,midpoint,90.97,84.68,0.9107,0,2.749
MA22VaccineCohort,AUS24_s006_prevax,A/Thailand/8/2022,plate40-CATAAAAGACTGTATA,96.44,interpolated,midpoint,105.7,96.44,0.8643,0,3.461
MA22VaccineCohort,AUS24_s006_prevax,A/Thailand/8/2022,plate40-AGACCATCGCACCCAA,128.5,interpolated,midpoint,141.2,128.5,0.9407,0,1.331
MA22VaccineCohort,AUS24_s006_prevax,A/Thailand/8/2022,plate40-CGTACGTATGTCCCAG,91.02,interpolated,midpoint,95.59,91.02,0.9218,0,3.474
MA22VaccineCohort,AUS24_s006_prevax,A/Malaysia/IMR-SARI1989/2023,plate40-TAATAACTTGAGATTC,60.08,interpolated,midpoint,68.07,60.08,0.851,0,2.836
MA22VaccineCohort,AUS24_s006_prevax,A/Malaysia/IMR-SARI1989/2023,plate40-AATTACGCATAGGCCA,105.4,interpolated,midpoint,107,105.4,0.9848,0,2.044
MA22VaccineCohort,AUS24_s006_prevax,A/Malaysia/IMR-SARI1989/2023,plate40-TCAAACTATGATATTC,75.38,interpolated,midpoint,83.45,75.38,0.8837,0,2.607
MA22VaccineCohort,AUS24_s006_prevax,A/Victoria/1033/2023,plate40-TCTTACATTGAAAGGC,76.12,interpolated,midpoint,81.46,76.12,0.9257,0,2.373
MA22VaccineCohort,AUS24_s006_prevax,A/Victoria/1033/2023,plate40-AACGACAACCATGAAT,71.45,interpolated,midpoint,76.33,71.45,0.928,0,2.356
MA22VaccineCohort,AUS24_s006_prevax,A/Victoria/1033/2023,plate40-ATCGATTCGATTGACG,85.05,interpolated,midpoint,86.38,85.05,0.9847,0,2
MA22VaccineCohort,AUS24_s006_prevax,A/Guangdong-Futian/1980/2023,plate40-TTATGTTTTAATGGTA,46.87,interpolated,midpoint,48.39,46.87,0.8633,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Guangdong-Futian/1980/2023,plate40-ACAAAGATAAAAATTT,102.9,interpolated,midpoint,106.7,102.9,0.9833,0,0.9459
MA22VaccineCohort,AUS24_s006_prevax,A/Guangdong-Futian/1980/2023,plate40-ATGCGTCTAAACATAG,91.69,interpolated,midpoint,94.83,91.69,0.9744,0,1.563
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/749/2023,plate40-TCGTCCTAGAACCTAA,105.9,interpolated,midpoint,133.5,105.9,0.8167,0,1.971
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/749/2023,plate40-GTAGAAACTAGGAGTT,99.66,interpolated,midpoint,110.7,99.66,0.9086,0,1.918
MA22VaccineCohort,AUS24_s006_prevax,A/Sydney/749/2023,plate40-AGCAGACACTTTACAT,114.7,interpolated,midpoint,148.3,114.7,0.8081,0,1.887
MA22VaccineCohort,AUS24_s006_prevax,A/Cambodia/e0826360/2020_egg,plate40-ATAACGTTTGTGCAAA,135.5,interpolated,midpoint,144.7,135.5,0.9114,0,2.964
MA22VaccineCohort,AUS24_s006_prevax,A/Cambodia/e0826360/2020_egg,plate40-TGTTGTAATCTGAATA,144,interpolated,midpoint,146,144,0.9835,0,2.424
MA22VaccineCohort,AUS24_s006_prevax,A/Cambodia/e0826360/2020_egg,plate40-AAATTCACAATATCCA,141.8,interpolated,midpoint,154.1,141.8,0.9183,0,2.144
MA22VaccineCohort,AUS24_s006_prevax,A/Darwin/9/2021,plate40-CAAAAGCAGCACGATA,122.5,interpolated,midpoint,136.6,122.5,0.8846,0,2.413
MA22VaccineCohort,AUS24_s006_prevax,A/Darwin/9/2021,plate40-AAAGTAGCAGAGGATT,121.9,interpolated,midpoint,125.5,121.9,0.9665,0,2.361
MA22VaccineCohort,AUS24_s006_prevax,A/Darwin/9/2021,plate40-CGTTAACGGCCTATCC,118.6,interpolated,midpoint,119.8,118.6,0.9847,0,3.189
MA22VaccineCohort,AUS24_s006_prevax,A/Texas/50/2012,plate40-TGAGTTCATAGCTCCA,185.5,interpolated,midpoint,210.4,185.5,0.812,0,3.738
MA22VaccineCohort,AUS24_s006_prevax,A/Texas/50/2012,plate40-AACCGTACCGCGTTTA,221.8,interpolated,midpoint,234.7,221.8,0.9107,0,3.476
MA22VaccineCohort,AUS24_s006_prevax,A/Texas/50/2012,plate40-AGTTCCATAGGCATGG,209.9,interpolated,midpoint,219.8,209.9,0.9635,0,1.653
MA22VaccineCohort,AUS24_s006_prevax,A/Singapore/INFIMH-16-0019/2016_X-307A,plate40-CAGATAGTGATGAACA,135.3,interpolated,midpoint,169.7,135.3,0.7727,0,2.671
MA22VaccineCohort,AUS24_s006_prevax,A/Singapore/INFIMH-16-0019/2016_X-307A,plate40-AAAGACCTTTAACTCT,124.6,interpolated,midpoint,137.9,124.6,0.8859,0,2.559
MA22VaccineCohort,AUS24_s006_prevax,A/Singapore/INFIMH-16-0019/2016_X-307A,plate40-GTAATTCGCATGCGGA,136.4,interpolated,midpoint,154.7,136.4,0.8211,0,3.518
MA22VaccineCohort,AUS24_s006_prevax,A/Texas/50/2012_X-223A_(13/252),plate40-ATAGAAAATTATCCGC,210.1,interpolated,midpoint,244.8,210.1,0.829,0,2.739
MA22VaccineCohort,AUS24_s006_prevax,A/Texas/50/2012_X-223A_(13/252),plate40-ACGCAAATAGACCGAA,178.7,interpolated,midpoint,184.4,178.7,0.8647,0,10
MA22VaccineCohort,AUS24_s006_prevax,A/Texas/50/2012_X-223A_(13/252),plate40-TCCCCGTGGTTTGACA,359.7,interpolated,midpoint,368.8,359.7,0.9699,0,2.499
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/4801/2014_(15/192),plate40-ATTTACTCATTATACG,374.2,interpolated,midpoint,374.2,374.2,1,0,1.421
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/4801/2014_(15/192),plate40-CACAGACAATAAAAAA,203.9,interpolated,midpoint,211.5,203.9,0.9543,0,2.629
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/4801/2014_(15/192),plate40-GGTTAACTTTGGAAGC,179.8,interpolated,midpoint,195.7,179.8,0.8471,0,4.284
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/2671/2019,plate40-CGAAAACATTACAAAT,186.6,interpolated,midpoint,195.7,186.6,0.8806,0,5.708
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/2671/2019,plate40-CGGGAATCTCCCATAC,232.6,interpolated,midpoint,256.9,232.6,0.8688,0,3.068
MA22VaccineCohort,AUS24_s006_prevax,A/Hong_Kong/2671/2019,plate40-TTCATCAAGTTGGTGC,178.9,interpolated,midpoint,183.9,178.9,0.9142,0,6.745
